This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
ASCO 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
EAU 2011 - Differences in biochemical recurrence rate after focal and extensive positive surgical margins following radical prostatectomy - Session Highlights
May 10, 2011
Oxidative stress measured by urine F2-Isoprostane level is associated with prostate cancer - Abstract
May 9, 2011
Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer - Abstract
May 9, 2011
Trends in mortality from urologic cancers in Europe, 1970-2008 - Abstract
May 9, 2011
The CT flare response of metastatic bone disease in prostate cancer - Abstract
May 9, 2011
In vivo imaging of intraprostatic-specific gene transcription by PET - Abstract
May 9, 2011
Prolonged response to early docetaxel in a patient with biochemical relapse after primary therapy for prostate cancer and incomplete response to androgen suppression therapy - Abstract
May 9, 2011
Statins and prostate cancer diagnosis and grade in a veterans population - Abstract
May 9, 2011
Investigative clinical study on prostate cancer part v: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population - Abstract
May 9, 2011
BJUI Mini Reviews - Evidence-based medicine: Comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate
May 9, 2011
EAU 2011 - Clinical benefit of cabazitaxel plus prednisone in the TROPIC trial in men with metastatic castration resistant prostate cancer (mCRPC) who progressed after docetaxel-based treatment - Session Highlights
May 9, 2011
EAU 2011 - Long-term efficacy results from the phase 1-2 study of MDV3100 in pre- and post-docetaxel advanced prostate cancer - Session Highlights
May 9, 2011
EAU 2011 - Clinical utility of PCA3 urine assay in Japanese men undergoing prostate biopsy - Session Highlights
May 9, 2011
EAU 2011 - Deregulation of miR339 in prostate cancer and metastases - Session Highlights
May 9, 2011
Cigarette smoking and prostate cancer recurrence after prostatectomy - Abstract
May 8, 2011
Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer - Abstract
May 7, 2011
Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions - Abstract
May 6, 2011
Delay of surgery in men with low risk prostate cancer - Abstract
May 6, 2011
Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments - Abstract
May 6, 2011
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer - Abstract
May 6, 2011
Page 1395 of 1428
Start
Prev
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free